Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis.
Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis.
复制标题
DOI：
10.3389/fphar.2023.1226008
复制
发表时间：
2023
影响因子：
5.6
通讯作者：
中科院分区：
文献类型：
--
作者：
Background: Astragaloside IV (ASIV) is the primary pharmacologically active compound found in Astragalus propinquus Schischkin, which has potential protective effects on cardiac function. However, there are almost no systematic evaluations of ASIV for the treatment of heart failure (HF). Methods: Preclinical studies published before 27 December 2022, were retrieved from PubMed, Web of Science, MEDLINE, SinoMed, Chinese National Knowledge Infrastructure (CNKI), VIP information database, and Wanfang Data information site. The quality of included research was evaluated using SYRCLE’s RoB tool. Review Manager 5.4.1 was used to perform meta-analyses of the cardiac function parameters and other indicators. Regression analysis was conducted to observe the dose-efficacy relationship. Results: Nineteen studies involving 489 animals were included. Results indicated that compared with the control group, ASIV could enhance cardiac function indicators, including left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular pressure change rate (±dp/dtmax), left ventricular end-diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP), heart weight/body weight (HW/BW) and left ventricular weight/body weight (LVW/BW). Furthermore, the regression analysis showed that the treatment of HF with ASIV was dose-dependent. Conclusion: Findings suggest that ASIV can inhibit cardiac hypertrophy by reducing cardiac preload and afterload, thereby protecting cardiac function.
登录
查看更多内容
影响因子：
3.5
作者：
Hu X;Luo H;Dou C;Chen X;Huang Y;Wang L;Xue S;Sun Z;Chen S;Xu Q;Geng T;Zhao X;Cui H
通讯作者：
Cui H
影响因子：
2.9
作者：
Guo Hong-xin;Wang Jian-ru;Zhu Ming-jun
通讯作者：
Zhu Ming-jun
DOI：
10.1038/s41572-020-0151-7
发表时间：
2020-03-05
期刊：
Nature reviews. Disease primers
影响因子：
--
作者：
Arrigo M;Jessup M;Mullens W;Reza N;Shah AM;Sliwa K;Mebazaa A
通讯作者：
Mebazaa A
DOI：
10.1161/hhf.0b013e318291329a
发表时间：
2013-05
期刊：
Circulation. Heart failure
影响因子：
--
作者：
Heidenreich PA;Albert NM;Allen LA;Bluemke DA;Butler J;Fonarow GC;Ikonomidis JS;Khavjou O;Konstam MA;Maddox TM;Nichol G;Pham M;Piña IL;Trogdon JG;American Heart Association Advocacy Coordinating Committee;Council on Arteriosclerosis, Thrombosis and Vascular Biology;Council on Cardiovascular Radiology and Intervention;Council on Clinical Cardiology;Council on Epidemiology and Prevention;Stroke Council
通讯作者：
Stroke Council
影响因子：
64.8
作者：
Landis, Story C.;Amara, Susan G.;Asadullah, Khusru;Austin, Chris P.;Blumenstein, Robi;Bradley, Eileen W.;Crystal, Ronald G.;Darnell, Robert B.;Ferrante, Robert J.;Fillit, Howard;Finkelstein, Robert;Fisher, Marc;Gendelman, Howard E.;Golub, Robert M.;Goudreau, John L.;Gross, Robert A.;Gubitz, Amelie K.;Hesterlee, Sharon E.;Howells, David W.;Huguenard, John;Kelner, Katrina;Koroshetz, Walter;Krainc, Dimitri;Lazic, Stanley E.;Levine, Michael S.;Macleod, Malcolm R.;McCall, John M.;Moxley, Richard T., III;Narasimhan, Kalyani;Noble, Linda J.;Perrin, Steve;Porter, John D.;Steward, Oswald;Unger, Ellis;Utz, Ursula;Silberberg, Shai D.
通讯作者：
Silberberg, Shai D.